• BD and M&A evaluations:
    providing sound judgment where it matters most!
  • Negotiation with Health Authorities:
    integrating scientific / clinical / regulatory know-how for success
  • Criteria for Proof-of-Concept:
    developing TPPs / CDPs with an eye on feasibility
    establishing early efficacy/safety read-outs for a streamlined development path
  • Feasibility assessment:
    avoiding project commitments with low likelihood of success
  • Drug Safety / Pharmacovigilance / QA-QC:
    evaluations of AEs, contaminants, formulation issues
  • Medical Affairs:
    conference coverage and competitive insights
Print Friendly